145 related articles for article (PubMed ID: 22217649)
1. Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.
Kim S; Tannock I; Sridhar S; Seki J; Bordeleau L
J Oncol Pharm Pract; 2012 Jun; 18(2):311-5. PubMed ID: 22217649
[TBL] [Abstract][Full Text] [Related]
2. Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature.
Mileshkin L; Prince HM; Rischin D; Zimet A
Bone Marrow Transplant; 2001 Mar; 27(5):559-63. PubMed ID: 11313694
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic breast cancer: new chemotherapy regimens with taxanes].
Lopez M
Clin Ter; 2005; 156(6):311-5. PubMed ID: 16463568
[TBL] [Abstract][Full Text] [Related]
4. Five Cases of Interstitial Pneumonitis Due to Gemcitabine and Nab-Paclitaxel Combination Treatment in Pancreatic Cancer Patients.
Ogawa Y; Suzuki E; Mikata R; Yasui S; Abe M; Iino Y; Ohyama H; Chiba T; Tsuyuguchi T; Kato N
Pancreas; 2018 Aug; 47(7):e42-e43. PubMed ID: 29985849
[No Abstract] [Full Text] [Related]
5. Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin.
Meng L; Huang L; Xu Y; Zhang W
Cancer Chemother Pharmacol; 2020 Jan; 85(1):3-7. PubMed ID: 31377831
[TBL] [Abstract][Full Text] [Related]
6. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino GR; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
Ann Oncol; 2000 Mar; 11(3):367-71. PubMed ID: 10811508
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.
Chen YM; Perng RP; Lin WC; Wu HW; Tsai CM; Whang-Peng J
Am J Clin Oncol; 2002 Oct; 25(5):509-12. PubMed ID: 12393994
[TBL] [Abstract][Full Text] [Related]
8. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
Cinieri S; Chan A; Altundag K; Vandebroek A; Tubiana-Mathieu N; Barnadas A; Dodyk P; Lazzarelli S; Botha M; Rauch D; Villanova G; Coskun U
Clin Breast Cancer; 2017 Apr; 17(2):91-99.e1. PubMed ID: 27756583
[TBL] [Abstract][Full Text] [Related]
9. Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.
Metro G; Fabi A; Russillo M; Papaldo P; De Laurentiis M; Ferretti G; Pellegrini D; Nuzzo C; Graziano V; Vici P; Introna M; Felici A; Cognetti F; Carlini P
Anticancer Res; 2008; 28(2B):1245-58. PubMed ID: 18505062
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report.
Citarrella P; Gebbia V; Teresi M; Miceli S; Sciortino G; Vaglica M; Pizzardi N; Palmeri S
Anticancer Res; 2002; 22(2B):1183-5. PubMed ID: 12168922
[TBL] [Abstract][Full Text] [Related]
11. Interstitial lung disease associated with docetaxel in a patient treated for breast cancer - a case report.
Pankowska-Supryn M; Załęska M; Roszkowska-Śliż B; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2015; 83(5):378-82. PubMed ID: 26378999
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
Georgoulias VA
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):18-24. PubMed ID: 11252884
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).
McCarthy N; Boyle F; Zdenkowski N; Bull J; Leong E; Simpson A; Kannourakis G; Francis PA; Chirgwin J; Abdi E; Gebski V; Veillard AS; Zannino D; Wilcken N; Reaby L; Lindsay DF; Badger HD; Forbes JF;
Breast; 2014 Apr; 23(2):142-51. PubMed ID: 24393617
[TBL] [Abstract][Full Text] [Related]
14. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
Brugnatelli S; Danova M; De Bella MT; Vaglica M; Manuguerra G; Riccardi A; Palmeri S
Oncology; 2002; 62(1):33-8. PubMed ID: 11810041
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Raderer M; Schüll B; Payrits T; Depisch D; Kovats E; Lang F; Scheithauer W
Clin Cancer Res; 2002 May; 8(5):1051-6. PubMed ID: 12006518
[TBL] [Abstract][Full Text] [Related]
16. Non-platinum combination of gemcitabine in NSCLC.
Favaretto AG
Ann Oncol; 2006 May; 17 Suppl 5():v82-5. PubMed ID: 16807471
[No Abstract] [Full Text] [Related]
17. Gemcitabine and taxanes in metastatic breast cancer.
Amadori D; Cecconetto L
Ann Oncol; 2006 May; 17 Suppl 5():v173-6. PubMed ID: 16807451
[No Abstract] [Full Text] [Related]
18. Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study.
Watanabe T; Kuranami M; Inoue K; Masuda N; Aogi K; Ohno S; Iwata H; Mukai H; Uemura Y; Ohashi Y
Cancer; 2017 Mar; 123(5):759-768. PubMed ID: 28081304
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer.
Jinno H; Sakata M; Hayashida T; Takahashi M; Mukai M; Ikeda T; Kitagawa Y
Ann Oncol; 2010 Jun; 21(6):1262-1266. PubMed ID: 19854722
[TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Ann Oncol; 1999 Feb; 10(2):211-5. PubMed ID: 10093691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
